PLK1 and lung adenocarcinoma: The Polo-like kinase 1 (PLK1) pathway is crucial for cell cycle regulation and mitotic progression, and its overexpression has been associated with poor prognosis in various cancers, including lung adenocarcinoma (LUAD) (46).